Home/ Stocks/ ACLX

Arcellx, Inc. Common Stock

ACLX XNAS

$113.96 +49.84 (+77.75%) ▲ 15-min delayed

Open

$114.14

High

$114.26

Low

$113.80

Volume

11.06M

Market Cap

$3.71B

About Arcellx, Inc. Common Stock

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 163 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$4.95M	$-55,781,000	$-0.99
Q2 2025	$7.55M	$-52,771,000	$-0.94
Q1 2025	$8.13M	$-62,270,000	$-1.13
Q3 2024	$26.03M	$-25,867,000	$-0.48

Ticker Daily Articles on ACLX

Why Is Arcellx, Inc. Common Stock (ACLX) Stock Up 77.8% Today?

Alex Chen · 3h ago · Market News

Why Is Arcellx, Inc. Common Stock (ACLX) Stock Up 78.1% Today?

Alex Chen · 3h ago · Market News

Get ACLX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Arcellx, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.